NIH Public Access Policy
In accordance with Division G, Title II, Section 218 of PL 110-161 (Consolidated Appropriations Act, 2008 ), the NIH voluntary Public Access Policy (NOT-OD-05-022) is now mandatory.
The new policy is effective April 7, 2008. All accepted, peer-reviewed manuscripts (not the print-ready copy) arising, in whole or in part, from direct costs funded by NIH, must be submitted to PubMed Central upon acceptance for publication. These manuscripts will be made publicly available on PubMed Central within 12 months of the publication date.
Beginning May 25, 2008, all NIH applications, proposals, and progress reports must include the PubMed Central reference number (PMCID) when citing an article that falls under the policy and is authored or co-authored by the investigator or arose from the investigator's NIH award.
Beginning August 21, 2009, the NIH Manuscript Submission ID (NIHMSID) may be used to indicate compliance for up to three (3) months after a paper is published. After that period, a PMCID must be provided. See Clarification on the Use of an NIHMSID and Locating the PMCID from NIH.
It is important to comply with this policy in its entirety. NIH has indicated that a failure to comply with this statutory requirement may delay a future grant or jeopardize future research funding.
NIH Policy Presentations
Julie Schneider, Ebling Library's Assistant Director for Scholarly Communications, will hold information sessions about the NIH Public Access Policy for research groups and departments (PowerPoint slides). See her contact information below.
Benefits of the Policy
- It will lead to broader possibilities for advancing science through 24/7 worldwide access to research and scholarship.
- It will increase the visibility of your research.
- It will preserve research publications for the long term.
- Articles in PubMed Central may be fully integrated with other databases developed and supported by NIH including PubMed, GenBank, PubChem, and many others.
Questions?
Contact Julie Schneider, Ebling Library, with questions about the NIH public-access policy.